Industry Research Reports

Home > Reports > Pharma & Healthcare > Cetuximab Biosimilar - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Cetuximab Biosimilar - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-11

Pages: 104 Pages

Report ld: 3028349

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Cetuximab Biosimilar was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Cetuximab Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cetuximab Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Cetuximab Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Cetuximab Biosimilar include Actavis, Amgen, Celltrion, Pfizer, Bio X Cell, Wuhan Dima Biotechnology and Guangdong ANNPO Biotechnology, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Cetuximab Biosimilar, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cetuximab Biosimilar by region & country, by Type, and by Application.

The Cetuximab Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cetuximab Biosimilar.

Market Segmentation

Report Metric
Details
Report Title
Cetuximab Biosimilar - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Cetuximab Biosimilar Companies Covered
Actavis, Amgen, Celltrion, Pfizer, Bio X Cell, Wuhan Dima Biotechnology, Guangdong ANNPO Biotechnology
Global Cetuximab Biosimilar Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cetuximab Biosimilar Market, Segment by Type
100 mg/50 mL Injection

200 mg/100 mL Injection
Global Cetuximab Biosimilar Market, Segment by Application
Metastatic colorectal cancer

Metastatic breast cancer

Non-small cell lung cancer

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cetuximab Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cetuximab Biosimilar in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cetuximab Biosimilar in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Cetuximab Biosimilar Product Introduction
    1.2 Global Cetuximab Biosimilar Market Size Forecast
        1.2.1 Global Cetuximab Biosimilar Sales Value (2019-2030)
        1.2.2 Global Cetuximab Biosimilar Sales Volume (2019-2030)
        1.2.3 Global Cetuximab Biosimilar Sales Price (2019-2030)
    1.3 Cetuximab Biosimilar Market Trends & Drivers
        1.3.1 Cetuximab Biosimilar Industry Trends
        1.3.2 Cetuximab Biosimilar Market Drivers & Opportunity
        1.3.3 Cetuximab Biosimilar Market Challenges
        1.3.4 Cetuximab Biosimilar Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Cetuximab Biosimilar Players Revenue Ranking (2023)
    2.2 Global Cetuximab Biosimilar Revenue by Company (2019-2024)
    2.3 Global Cetuximab Biosimilar Players Sales Volume Ranking (2023)
    2.4 Global Cetuximab Biosimilar Sales Volume by Company Players (2019-2024)
    2.5 Global Cetuximab Biosimilar Average Price by Company (2019-2024)
    2.6 Key Manufacturers Cetuximab Biosimilar Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Cetuximab Biosimilar Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Cetuximab Biosimilar
    2.9 Cetuximab Biosimilar Market Competitive Analysis
        2.9.1 Cetuximab Biosimilar Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Cetuximab Biosimilar Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cetuximab Biosimilar as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 100 mg/50 mL Injection
        3.1.2 200 mg/100 mL Injection
    3.2 Global Cetuximab Biosimilar Sales Value by Type
        3.2.1 Global Cetuximab Biosimilar Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Cetuximab Biosimilar Sales Value, by Type (2019-2030)
        3.2.3 Global Cetuximab Biosimilar Sales Value, by Type (%) (2019-2030)
    3.3 Global Cetuximab Biosimilar Sales Volume by Type
        3.3.1 Global Cetuximab Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Cetuximab Biosimilar Sales Volume, by Type (2019-2030)
        3.3.3 Global Cetuximab Biosimilar Sales Volume, by Type (%) (2019-2030)
    3.4 Global Cetuximab Biosimilar Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Metastatic colorectal cancer
        4.1.2 Metastatic breast cancer
        4.1.3 Non-small cell lung cancer
        4.1.4 Other
    4.2 Global Cetuximab Biosimilar Sales Value by Application
        4.2.1 Global Cetuximab Biosimilar Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Cetuximab Biosimilar Sales Value, by Application (2019-2030)
        4.2.3 Global Cetuximab Biosimilar Sales Value, by Application (%) (2019-2030)
    4.3 Global Cetuximab Biosimilar Sales Volume by Application
        4.3.1 Global Cetuximab Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Cetuximab Biosimilar Sales Volume, by Application (2019-2030)
        4.3.3 Global Cetuximab Biosimilar Sales Volume, by Application (%) (2019-2030)
    4.4 Global Cetuximab Biosimilar Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Cetuximab Biosimilar Sales Value by Region
        5.1.1 Global Cetuximab Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Cetuximab Biosimilar Sales Value by Region (2019-2024)
        5.1.3 Global Cetuximab Biosimilar Sales Value by Region (2025-2030)
        5.1.4 Global Cetuximab Biosimilar Sales Value by Region (%), (2019-2030)
    5.2 Global Cetuximab Biosimilar Sales Volume by Region
        5.2.1 Global Cetuximab Biosimilar Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Cetuximab Biosimilar Sales Volume by Region (2019-2024)
        5.2.3 Global Cetuximab Biosimilar Sales Volume by Region (2025-2030)
        5.2.4 Global Cetuximab Biosimilar Sales Volume by Region (%), (2019-2030)
    5.3 Global Cetuximab Biosimilar Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Cetuximab Biosimilar Sales Value, 2019-2030
        5.4.2 North America Cetuximab Biosimilar Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Cetuximab Biosimilar Sales Value, 2019-2030
        5.5.2 Europe Cetuximab Biosimilar Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Cetuximab Biosimilar Sales Value, 2019-2030
        5.6.2 Asia Pacific Cetuximab Biosimilar Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Cetuximab Biosimilar Sales Value, 2019-2030
        5.7.2 South America Cetuximab Biosimilar Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Cetuximab Biosimilar Sales Value, 2019-2030
        5.8.2 Middle East & Africa Cetuximab Biosimilar Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Cetuximab Biosimilar Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Cetuximab Biosimilar Sales Value
        6.2.1 Key Countries/Regions Cetuximab Biosimilar Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Cetuximab Biosimilar Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Cetuximab Biosimilar Sales Value, 2019-2030
        6.3.2 United States Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Cetuximab Biosimilar Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Cetuximab Biosimilar Sales Value, 2019-2030
        6.4.2 Europe Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Cetuximab Biosimilar Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Cetuximab Biosimilar Sales Value, 2019-2030
        6.5.2 China Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Cetuximab Biosimilar Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Cetuximab Biosimilar Sales Value, 2019-2030
        6.6.2 Japan Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Cetuximab Biosimilar Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Cetuximab Biosimilar Sales Value, 2019-2030
        6.7.2 South Korea Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Cetuximab Biosimilar Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Cetuximab Biosimilar Sales Value, 2019-2030
        6.8.2 Southeast Asia Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Cetuximab Biosimilar Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Cetuximab Biosimilar Sales Value, 2019-2030
        6.9.2 India Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Cetuximab Biosimilar Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Actavis
        7.1.1 Actavis Company Information
        7.1.2 Actavis Introduction and Business Overview
        7.1.3 Actavis Cetuximab Biosimilar Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Actavis Cetuximab Biosimilar Product Offerings
        7.1.5 Actavis Recent Development
    7.2 Amgen
        7.2.1 Amgen Company Information
        7.2.2 Amgen Introduction and Business Overview
        7.2.3 Amgen Cetuximab Biosimilar Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Amgen Cetuximab Biosimilar Product Offerings
        7.2.5 Amgen Recent Development
    7.3 Celltrion
        7.3.1 Celltrion Company Information
        7.3.2 Celltrion Introduction and Business Overview
        7.3.3 Celltrion Cetuximab Biosimilar Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Celltrion Cetuximab Biosimilar Product Offerings
        7.3.5 Celltrion Recent Development
    7.4 Pfizer
        7.4.1 Pfizer Company Information
        7.4.2 Pfizer Introduction and Business Overview
        7.4.3 Pfizer Cetuximab Biosimilar Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Pfizer Cetuximab Biosimilar Product Offerings
        7.4.5 Pfizer Recent Development
    7.5 Bio X Cell
        7.5.1 Bio X Cell Company Information
        7.5.2 Bio X Cell Introduction and Business Overview
        7.5.3 Bio X Cell Cetuximab Biosimilar Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Bio X Cell Cetuximab Biosimilar Product Offerings
        7.5.5 Bio X Cell Recent Development
    7.6 Wuhan Dima Biotechnology
        7.6.1 Wuhan Dima Biotechnology Company Information
        7.6.2 Wuhan Dima Biotechnology Introduction and Business Overview
        7.6.3 Wuhan Dima Biotechnology Cetuximab Biosimilar Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Wuhan Dima Biotechnology Cetuximab Biosimilar Product Offerings
        7.6.5 Wuhan Dima Biotechnology Recent Development
    7.7 Guangdong ANNPO Biotechnology
        7.7.1 Guangdong ANNPO Biotechnology Company Information
        7.7.2 Guangdong ANNPO Biotechnology Introduction and Business Overview
        7.7.3 Guangdong ANNPO Biotechnology Cetuximab Biosimilar Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Guangdong ANNPO Biotechnology Cetuximab Biosimilar Product Offerings
        7.7.5 Guangdong ANNPO Biotechnology Recent Development

 8 Industry Chain Analysis
    8.1 Cetuximab Biosimilar Industrial Chain
    8.2 Cetuximab Biosimilar Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Cetuximab Biosimilar Sales Model
        8.5.2 Sales Channel
        8.5.3 Cetuximab Biosimilar Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Cetuximab Biosimilar Market Trends
    Table 2. Cetuximab Biosimilar Market Drivers & Opportunity
    Table 3. Cetuximab Biosimilar Market Challenges
    Table 4. Cetuximab Biosimilar Market Restraints
    Table 5. Global Cetuximab Biosimilar Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Cetuximab Biosimilar Revenue Market Share by Company (2019-2024)
    Table 7. Global Cetuximab Biosimilar Sales Volume by Company (2019-2024) & (K Pcs)
    Table 8. Global Cetuximab Biosimilar Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Cetuximab Biosimilar Price by Company (2019-2024) & (US$/Pcs)
    Table 10. Key Manufacturers Cetuximab Biosimilar Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Cetuximab Biosimilar Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Cetuximab Biosimilar
    Table 13. Global Cetuximab Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cetuximab Biosimilar as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Cetuximab Biosimilar Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Cetuximab Biosimilar Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Cetuximab Biosimilar Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Cetuximab Biosimilar Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Cetuximab Biosimilar Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Cetuximab Biosimilar Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)
    Table 22. Global Cetuximab Biosimilar Sales Volume by Type (2019-2024) & (K Pcs)
    Table 23. Global Cetuximab Biosimilar Sales Volume by Type (2025-2030) & (K Pcs)
    Table 24. Global Cetuximab Biosimilar Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Cetuximab Biosimilar Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Cetuximab Biosimilar Price by Type (2019-2024) & (US$/Pcs)
    Table 27. Global Cetuximab Biosimilar Price by Type (2025-2030) & (US$/Pcs)
    Table 28. Global Cetuximab Biosimilar Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Cetuximab Biosimilar Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Cetuximab Biosimilar Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Cetuximab Biosimilar Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Cetuximab Biosimilar Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Cetuximab Biosimilar Sales Volume by Application: 2019 VS 2023 VS 2030 (K Pcs)
    Table 34. Global Cetuximab Biosimilar Sales Volume by Application (2019-2024) & (K Pcs)
    Table 35. Global Cetuximab Biosimilar Sales Volume by Application (2025-2030) & (K Pcs)
    Table 36. Global Cetuximab Biosimilar Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Cetuximab Biosimilar Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Cetuximab Biosimilar Price by Application (2019-2024) & (US$/Pcs)
    Table 39. Global Cetuximab Biosimilar Price by Application (2025-2030) & (US$/Pcs)
    Table 40. Global Cetuximab Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Cetuximab Biosimilar Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Cetuximab Biosimilar Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Cetuximab Biosimilar Sales Value by Region (2019-2024) & (%)
    Table 44. Global Cetuximab Biosimilar Sales Value by Region (2025-2030) & (%)
    Table 45. Global Cetuximab Biosimilar Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030
    Table 46. Global Cetuximab Biosimilar Sales Volume by Region (2019-2024) & (K Pcs)
    Table 47. Global Cetuximab Biosimilar Sales Volume by Region (2025-2030) & (K Pcs)
    Table 48. Global Cetuximab Biosimilar Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Cetuximab Biosimilar Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Cetuximab Biosimilar Average Price by Region (2019-2024) & (US$/Pcs)
    Table 51. Global Cetuximab Biosimilar Average Price by Region (2025-2030) & (US$/Pcs)
    Table 52. Key Countries/Regions Cetuximab Biosimilar Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Cetuximab Biosimilar Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Cetuximab Biosimilar Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Cetuximab Biosimilar Sales Volume, (2019-2024) & (K Pcs)
    Table 56. Key Countries/Regions Cetuximab Biosimilar Sales Volume, (2025-2030) & (K Pcs)
    Table 57. Actavis Company Information
    Table 58. Actavis Introduction and Business Overview
    Table 59. Actavis Cetuximab Biosimilar Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 60. Actavis Cetuximab Biosimilar Product Offerings
    Table 61. Actavis Recent Development
    Table 62. Amgen Company Information
    Table 63. Amgen Introduction and Business Overview
    Table 64. Amgen Cetuximab Biosimilar Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 65. Amgen Cetuximab Biosimilar Product Offerings
    Table 66. Amgen Recent Development
    Table 67. Celltrion Company Information
    Table 68. Celltrion Introduction and Business Overview
    Table 69. Celltrion Cetuximab Biosimilar Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 70. Celltrion Cetuximab Biosimilar Product Offerings
    Table 71. Celltrion Recent Development
    Table 72. Pfizer Company Information
    Table 73. Pfizer Introduction and Business Overview
    Table 74. Pfizer Cetuximab Biosimilar Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 75. Pfizer Cetuximab Biosimilar Product Offerings
    Table 76. Pfizer Recent Development
    Table 77. Bio X Cell Company Information
    Table 78. Bio X Cell Introduction and Business Overview
    Table 79. Bio X Cell Cetuximab Biosimilar Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 80. Bio X Cell Cetuximab Biosimilar Product Offerings
    Table 81. Bio X Cell Recent Development
    Table 82. Wuhan Dima Biotechnology Company Information
    Table 83. Wuhan Dima Biotechnology Introduction and Business Overview
    Table 84. Wuhan Dima Biotechnology Cetuximab Biosimilar Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 85. Wuhan Dima Biotechnology Cetuximab Biosimilar Product Offerings
    Table 86. Wuhan Dima Biotechnology Recent Development
    Table 87. Guangdong ANNPO Biotechnology Company Information
    Table 88. Guangdong ANNPO Biotechnology Introduction and Business Overview
    Table 89. Guangdong ANNPO Biotechnology Cetuximab Biosimilar Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
    Table 90. Guangdong ANNPO Biotechnology Cetuximab Biosimilar Product Offerings
    Table 91. Guangdong ANNPO Biotechnology Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Cetuximab Biosimilar Downstream Customers
    Table 95. Cetuximab Biosimilar Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cetuximab Biosimilar Product Picture
    Figure 2. Global Cetuximab Biosimilar Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cetuximab Biosimilar Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Cetuximab Biosimilar Sales Volume (2019-2030) & (K Pcs)
    Figure 5. Global Cetuximab Biosimilar Sales Price (2019-2030) & (US$/Pcs)
    Figure 6. Cetuximab Biosimilar Report Years Considered
    Figure 7. Global Cetuximab Biosimilar Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Cetuximab Biosimilar Players Sales Volume Ranking (2023) & (K Pcs)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cetuximab Biosimilar Revenue in 2023
    Figure 10. Cetuximab Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 100 mg/50 mL Injection Picture
    Figure 12. 200 mg/100 mL Injection Picture
    Figure 13. Global Cetuximab Biosimilar Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Cetuximab Biosimilar Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Cetuximab Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 16. Global Cetuximab Biosimilar Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Cetuximab Biosimilar Price by Type (2019-2030) & (US$/Pcs)
    Figure 18. Product Picture of Metastatic colorectal cancer
    Figure 19. Product Picture of Metastatic breast cancer
    Figure 20. Product Picture of Non-small cell lung cancer
    Figure 21. Product Picture of Other
    Figure 22. Global Cetuximab Biosimilar Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Cetuximab Biosimilar Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Cetuximab Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 25. Global Cetuximab Biosimilar Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Cetuximab Biosimilar Price by Application (2019-2030) & (US$/Pcs)
    Figure 27. North America Cetuximab Biosimilar Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Cetuximab Biosimilar Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Cetuximab Biosimilar Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Cetuximab Biosimilar Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Cetuximab Biosimilar Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Cetuximab Biosimilar Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Cetuximab Biosimilar Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Cetuximab Biosimilar Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Cetuximab Biosimilar Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Cetuximab Biosimilar Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Cetuximab Biosimilar Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Cetuximab Biosimilar Sales Volume (%), (2019-2030)
    Figure 39. United States Cetuximab Biosimilar Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Cetuximab Biosimilar Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Cetuximab Biosimilar Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Cetuximab Biosimilar Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Cetuximab Biosimilar Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Cetuximab Biosimilar Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Cetuximab Biosimilar Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Cetuximab Biosimilar Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Cetuximab Biosimilar Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Cetuximab Biosimilar Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Cetuximab Biosimilar Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Cetuximab Biosimilar Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Cetuximab Biosimilar Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Cetuximab Biosimilar Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Cetuximab Biosimilar Sales Value by Application (%), 2023 VS 2030
    Figure 60. Cetuximab Biosimilar Industrial Chain
    Figure 61. Cetuximab Biosimilar Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Description

The global market for Cetuximab Biosimilar was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Cetuximab Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cetuximab Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Cetuximab Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Cetuximab Biosimilar include Actavis, Amgen, Celltrion, Pfizer, Bio X Cell, Wuhan Dima Biotechnology and Guangdong ANNPO Biotechnology, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Cetuximab Biosimilar, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cetuximab Biosimilar by region & country, by Type, and by Application.

The Cetuximab Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cetuximab Biosimilar.

Market Segmentation